{"entity":{"id":"paper-kiros-paediatric-oncology-cea-ethiopia-bmjopen-2023","kind":"paper","name":"Cost-effectiveness of running a paediatric oncology unit in Ethiopia","aka":[],"tldr":"Running the paediatric oncology unit at Tikur Anbessa Specialized Hospital cost about 361 US dollars per disability-adjusted life year averted, which the authors judged cost-effective, and they recommended reassessing the low and medium priority that Ethiopia's essential package gives childhood cancer treatment.","summary":"A decision-tree model compared running a paediatric oncology unit with no paediatric oncology care, from a healthcare provider perspective, using 2018 to 2019 costing of the unit at Tikur Anbessa Specialized Hospital and outcome data from similar settings, over a lifetime horizon with 3% discounting. The willingness-to-pay threshold used was 50% of Ethiopia's GDP per capita, 477 US dollars in 2019.","asOf":"2026-11-04","links":[{"label":"BMJ Open 2023","url":"https://doi.org/10.1136/bmjopen-2022-068210"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/36918241/"}],"tags":[],"related":[],"cancers":["childhood-cancers"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["tikur-anbessa-hospital"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"BMJ Open","year":2023,"doi":"10.1136/bmjopen-2022-068210","pmid":"36918241","authors":"Kiros M, Memirie ST, Tolla MTT, et al.","paperType":"methods","findings":["Incremental cost per child treated was 876 US dollars and 2.4 disability-adjusted life years were averted per child.","The incremental cost-effectiveness ratio was 361 US dollars per DALY averted.","The unit was cost-effective in 90% of 100,000 Monte Carlo iterations at the 477 US dollar threshold."],"whatItMeans":"Evidence written to inform Ethiopia's next revision of its essential health services package, which ranks childhood cancer treatment at low and medium priority.","caveats":["Health outcomes were taken from other studies in similar settings, not measured at the unit.","The threshold is the authors' choice; OnCo found no official Ethiopian cost-effectiveness threshold."]},"route":"/key-papers/paper-kiros-paediatric-oncology-cea-ethiopia-bmjopen-2023/","neighbours":{"cancer":[{"id":"childhood-cancers","kind":"cancer","name":"Childhood cancers (all types)","route":"/cancers/childhood-cancers/"}],"institution":[{"id":"ethiopia-ministry-of-health","kind":"institution","name":"Federal Ministry of Health, Ethiopia","route":"/institutions/ethiopia-ministry-of-health/"},{"id":"tikur-anbessa-hospital","kind":"institution","name":"Tikur Anbessa Specialized Hospital, Addis Ababa University","route":"/institutions/tikur-anbessa-hospital/"}]}}